{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,7]],"date-time":"2024-06-07T16:33:34Z","timestamp":1717778014955},"reference-count":13,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2010,7,20]],"date-time":"2010-07-20T00:00:00Z","timestamp":1279584000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Int J of Rheum Dis"],"published-print":{"date-parts":[[2010,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:bold>Background:\u2002<\/jats:bold> Rheumatoid factors (RF) are currently used in the diagnosis of rheumatoid arthritis (RA). Several other autoantibodies found in RA are directed to epitopes in citrullinated proteins such as anti\u2010cyclic citrullinated and recently anti\u2010modified citrullinated vimentin (MCV).<\/jats:p><jats:p><jats:bold>Objective:\u2002<\/jats:bold> In this study we determined the sensitivity and specificity of anti\u2010MCV in comparison with anti\u2010cyclic citrullinated peptide (CCP) antibodies and RF in RA patients and in a control group using the American College of Rheumatology (ACR) criteria as the gold standard.<\/jats:p><jats:p><jats:bold>Materials and methods:\u2002<\/jats:bold> A cross sectional study was conducted from January to December 2008 on 100 patients with RA and 153 patients with arthritis or arthralgia but not fulfilling ACR criteria for RA. Serum from each subject was tested for anti\u2010MCV, anti\u2010CCP antibodies and immunoglobulin G (IgG) RF by enzyme\u2010linked immunosorbent assay. Sensitivity and specificity of the tests were evaluated using the ACR criteria as the gold standard.<\/jats:p><jats:p><jats:bold>Results:\u2002<\/jats:bold> The sensitivity of RF was 85% with 74.5% specificity. For anti\u2010CCP antibodies the sensitivity was 71% and the specificity was 94.8%. The sensitivity of anti\u2010MCV antibodies was 80% with 59.5% specificity. The area under the curve for RF was 0.759, for anti\u2010CCP antibodies was 0.866 and for anti\u2010MCV antibodies was 0.681, while for at least one positive test it was 0.691.<\/jats:p><jats:p><jats:bold>Conclusion:\u2002<\/jats:bold> Anti\u2010CCP antibodies have higher diagnostic specificity and positive predictive value than RF and anti\u2010MCV antibodies. RF has the highest sensitivity when compared to anti\u2010CCP and anti\u2010MCV antibodies. Thus anti\u2010MCV antibody is not a better marker when compared to RF or anti\u2010MCV antibody in the diagnosis of RA patients.<\/jats:p>","DOI":"10.1111\/j.1756-185x.2010.01552.x","type":"journal-article","created":{"date-parts":[[2010,7,20]],"date-time":"2010-07-20T07:14:23Z","timestamp":1279610063000},"page":"335-339","update-policy":"http:\/\/dx.doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Diagnostic value of anti\u2010modified citrullinated vimentin in rheumatoid arthritis"],"prefix":"10.1111","volume":"13","author":[{"given":"Che Hussin Che","family":"MARAINA","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdul Karim","family":"NURDAYANA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dollah","family":"RUSNI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaacob","family":"AZWANY","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2010,7,20]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.22089"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1186\/ar395"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1186\/ar551"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780310302"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1186\/ar2008"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1186\/ar1149"},{"key":"e_1_2_6_8_2","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/1529-0131(200001)43:1<155::AID-ANR20>3.0.CO;2-3","article-title":"The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide","volume":"43","author":"Schellekens GA","year":"2000","journal-title":"Arthritis Rheum"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.2174\/092986608783744153"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.23188"},{"issue":"9","key":"e_1_2_6_11_2","first-page":"S118","article-title":"A new powerful marker for the diagnosis and prognosis of rheumatoid arthritis: anti\u2010MCV antibodies","volume":"52","author":"Egerer K","year":"2005","journal-title":"Arthritis Rheum"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.080796"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1186\/ar1719"},{"key":"e_1_2_6_14_2","first-page":"1002","article-title":"Antibodies against mutated citrullinated vimentin are a better predictor of disease activity at 24\u2003months in early rheumatoid arthritis than antibodies against cyclic citrullinated peptides","volume":"35","author":"Innala L","year":"2008","journal-title":"J Rheumatol"}],"container-title":["International Journal of Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1756-185X.2010.01552.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1756-185X.2010.01552.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T21:10:09Z","timestamp":1697404209000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1756-185X.2010.01552.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7,20]]},"references-count":13,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,10]]}},"alternative-id":["10.1111\/j.1756-185X.2010.01552.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1756-185x.2010.01552.x","archive":["Portico"],"relation":{},"ISSN":["1756-1841","1756-185X"],"issn-type":[{"value":"1756-1841","type":"print"},{"value":"1756-185X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,7,20]]},"assertion":[{"value":"2010-07-20","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}